These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33182600)

  • 21. Four cases of bleeding diathesis in children due to congenital plasminogen activator inhibitor-1 deficiency.
    Minowa H; Takahashi Y; Tanaka T; Naganuma K; Ida S; Maki I; Yoshioka A
    Haemostasis; 1999; 29(5):286-91. PubMed ID: 10754381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor XIII, clot structure, thrombosis.
    Bagoly Z; Koncz Z; Hársfalvi J; Muszbek L
    Thromb Res; 2012 Mar; 129(3):382-7. PubMed ID: 22197181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and methodology of the impact of HemoDiaFIlTration on physical activity and self-reported outcomes: a randomized controlled trial (HDFIT trial) in Brazil.
    Pecoits-Filho R; Larkin JW; Poli-de-Figueiredo CE; Cuvello Neto AL; Barra AB; Canhada S; de Campos LG; Woehl J; Gonçalves PB; Han H; de Moraes TP; Raimann JG; Canziani MEF;
    BMC Nephrol; 2019 Mar; 20(1):98. PubMed ID: 30894141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patients.
    Jørgensen MB; Idorn T; Knop FK; Holst JJ; Hornum M; Feldt-Rasmussen B
    Nephrol Dial Transplant; 2015 Mar; 30(3):513-20. PubMed ID: 25319937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
    Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
    J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.
    Erdem Y; Haznedaroglu IC; Celik I; Yalcin AU; Yasavul U; Turgan C; Caglar S
    Nephrol Dial Transplant; 1996 Jul; 11(7):1299-305. PubMed ID: 8672026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration.
    Milovanova LY; Dobrosmyslov IA; Milovanov YS; Taranova MV; Kozlov VV; Milovanova SY; Kozevnikova EI
    Ter Arkh; 2018 Jun; 90(6):48-54. PubMed ID: 30701904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of high efficiency post-dilution on-line hemodiafiltration or conventional hemodialysis on residual renal function and left ventricular hypertrophy.
    Schiffl H; Lang SM; Fischer R
    Int Urol Nephrol; 2013 Oct; 45(5):1389-96. PubMed ID: 23225079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin-free renal replacement therapy for chronic hemodialyzed patients at high risk for bleeding: a comparison of on-line predilution hemodiafiltration with conventional hemodialysis.
    Brunot V; Serre JE; Mourad G; Klouche K; Pernin V
    Hemodial Int; 2018 Oct; 22(4):463-473. PubMed ID: 29745004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
    Muszbek L; Adány R; Mikkola H
    Crit Rev Clin Lab Sci; 1996; 33(5):357-421. PubMed ID: 8922891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
    He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
    Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review.
    Rabindranath KS; Strippoli GF; Roderick P; Wallace SA; MacLeod AM; Daly C
    Am J Kidney Dis; 2005 Mar; 45(3):437-47. PubMed ID: 15754266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.
    Mezei ZA; Katona É; Kállai J; Bereczky Z; Molnár É; Kovács B; Ajzner É; Bagoly Z; Miklós T; Muszbek L
    Thromb Res; 2016 Dec; 148():101-106. PubMed ID: 27821352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of advanced glycation end product levels by on-line hemodiafiltration in long-term hemodialysis patients.
    Lin CL; Huang CC; Yu CC; Yang HY; Chuang FR; Yang CW
    Am J Kidney Dis; 2003 Sep; 42(3):524-31. PubMed ID: 12955680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti-factor XIII autoantibodies.
    Ichinose A; Osaki T; Souri M
    Haemophilia; 2021 May; 27(3):454-462. PubMed ID: 33847063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
    Marcelli D; Bayh I; Merello JI; Ponce P; Heaton A; Kircelli F; Chazot C; Di Benedetto A; Marelli C; Ladanyi E; Kroczak M; Stuard S; Grassmann A; Scatizzi L; Brand K; Canaud B
    Kidney Int; 2016 Jul; 90(1):192-202. PubMed ID: 27178833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodiafiltration Versus Hemodialysis and Survival in Patients With ESRD: The French Renal Epidemiology and Information Network (REIN) Registry.
    Mercadal L; Franck JE; Metzger M; Urena Torres P; de Cornelissen F; Edet S; Béchade C; Vigneau C; Drüeke T; Jacquelinet C; Stengel B;
    Am J Kidney Dis; 2016 Aug; 68(2):247-255. PubMed ID: 26724836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antifibrinolytic function of factor XIII is exclusively expressed through α₂-antiplasmin cross-linking.
    Fraser SR; Booth NA; Mutch NJ
    Blood; 2011 Jun; 117(23):6371-4. PubMed ID: 21471521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter.
    Yu A; Egberg N; Jacobson SH
    Scand J Clin Lab Invest; 2003; 63(2):127-33. PubMed ID: 12751694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.